CLINICAL_TRIALS
trial_result
· 2014-10-23
Clinical Trial Update: Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure [Phase 1, Phase 2]
Summary
Clinical trial update on JVS-100 to assess safety and efficacy in adults with ischemic heart failure, spanning Phase 1 and Phase 2.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Juventas Therapeutics, Inc. | Conditions: Ischemic Heart Failure | Phase 1, Phase 2 | Status: UNKNOWN